VVEO3
ONconsolidatedCM Hospitalar S.A
CNPJ 12420164000157
—
Ratios
Q3 25 → Q2 26Share capital from the FRE dated 2026-12-31. The FRE is annual — buybacks and issuances after that date are not reflected here.
computed — The CVM does not publish Q4 on its own — the annual filing carries the full year. This figure is the year minus the first nine months.
Distributions
| Type | Approved on | Ex-date basis | R$ / share |
|---|---|---|---|
| DIVIDENDO | 2024-04-30 | 2024-04-30 | 0.136522 |
| JRS CAP PROPRIO | 2022-12-21 | 2022-12-26 | 0.276873 |
| DIVIDENDO | 2022-04-29 | 2022-04-29 | 0.157441 |
| JRS CAP PROPRIO | 2021-12-22 | 2021-12-28 | 0.248605 |
Gross amounts, by record date, from B3's registry — the Type column separates dividends, interest on equity and capital returns, and the 12-month yield adds all of them. A capital return is a refund, not income. Interest on equity (JCP) carries 15% withholding tax for individuals — the net yield is lower. Payment dates are not in this registry; they live in the shareholder notice.
Ratios by year
| Year | Revenue | Net income | Gross margin | Net margin | ROE | ROA | Turnover | Year-end price | P/E | DY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 11.57bn | 18.24m | 14.4% | 0.2% | 0.9% | 0.2% | 1.29 | 1.42 | 24.57 | — |
| 2024 | 11.58bn | -1.42bn | 11.3% | -12.2% | -73.5% | -14.8% | 1.21 | 2.05 | — | 6.7% |
| 2023 | 11.08bn | 359.92m | 15.7% | 3.3% | 10.9% | 3.5% | 1.09 | 13.95 | 11.63 | — |
| 2022 | 8.75bn | 259.73m | 16.0% | 3.0% | 11.4% | 2.7% | 0.91 | 16.13 | 17.62 | 2.7% |
| 2021 | 6.22bn | 395.16m | 17.7% | 6.4% | 18.4% | 5.7% | 0.90 | 18.87 | 12.50 | 1.3% |
| 2020 | 4.41bn | 121.77m | 14.5% | 2.8% | 10.1% | 2.7% | 0.96 | — | — | — |
From each fiscal year's DFP, with the close of the fiscal year-end month alongside. Yearly P/E and DY use the fiscal year-end close against that year's EPS and payouts — both already per share. An empty cell carries its reason in the tooltip: a loss, EPS out of scale, lot-of-a-thousand quoting, a split in the way. Yearly P/B is left out: it would need that year's share count, and the registration filing stores the latest approval's count under the reference date.
Quarterly results
| Period | Revenue | Operating | Net income | Net margin |
|---|---|---|---|---|
| Q2 26 | 2.91bn | 135.95m | -34.65m | -1.2% |
| Q1 26 | 2.83bn | 111.42m | -57.01m | -2.0% |
| Q4 25 | 3.13bn | 96.67m | -78.35m | -2.5% |
| Q3 25 | 2.83bn | 277.89m | 226.88m | 8.0% |
| Q2 25 | 2.82bn | 85.05m | -71.36m | -2.5% |
| Q1 25 | 2.78bn | 72.05m | -58.93m | -2.1% |
| Q4 24 | 2.92bn | -786.38m | -1.09bn | -37.5% |
| Q3 24 | 2.95bn | -180.41m | -237.74m | -8.0% |
| Q2 24 | 2.75bn | 34.05m | -87.72m | -3.2% |
| Q1 24 | 2.96bn | 69.76m | 3.04m | 0.1% |
| Q4 23 | 2.91bn | 118.47m | 261.24m | 9.0% |
| Q3 23 | 2.84bn | 167.63m | 6.32m | 0.2% |
Balance sheet
| Period | Total assets | Equity | Assets / Equity | Current ratio |
|---|---|---|---|---|
| Q2 26 | 8.76bn | 1.82bn | 4.81 | 1.72 |
| Q1 26 | 8.96bn | 1.88bn | 4.77 | 1.33 |
| Q4 25 | 8.98bn | 1.94bn | 4.64 | 1.33 |
| Q3 25 | 9.06bn | 2.01bn | 4.50 | 1.49 |
| Q2 25 | 9.20bn | 1.79bn | 5.15 | 1.74 |
| Q1 25 | 9.37bn | 1.87bn | 5.01 | 1.85 |
| Q4 24 | 9.54bn | 1.93bn | 4.95 | 1.85 |
| Q3 24 | 10.34bn | 3.01bn | 3.43 | 2.21 |
| Q2 24 | 10.53bn | 3.26bn | 3.23 | 2.37 |
| Q1 24 | 11.10bn | 3.29bn | 3.38 | 2.32 |
| Q4 23 | 10.19bn | 3.29bn | 3.10 | 1.95 |
| Q3 23 | 9.96bn | 3.13bn | 3.18 | 2.04 |
A balance sheet is a snapshot, not a window: there is no “computed Q4” here — December's figure is what the annual filing published.
What the company filed
| Filing | Period | Filed on | Days after close | Document |
|---|---|---|---|---|
| ITRT2 | 2026-06-30 | 2026-08-11 | 42 | CVM ↗ |
| ITRT1 | 2026-03-31 | 2026-05-14 | 44 | CVM ↗ |
| DFPanual | 2025-12-31 | 2026-03-05 | 64 | CVM ↗ |
| ITRT3 | 2025-09-30 | 2025-11-11 | 42 | CVM ↗ |
| ITRT2 | 2025-06-30 | 2025-08-12 | 43 | CVM ↗ |
| ITRT1 | 2025-03-31 | 2025-05-13 | 43 | CVM ↗ |
| DFPanual | 2024-12-31 | 2025-03-27 | 86 | CVM ↗ |
| ITRT3 | 2024-09-30 | 2024-11-13 | 44 | CVM ↗ |
| ITRT2 | 2024-06-30 | 2024-08-12 | 43 | CVM ↗ |
| ITRT1 | 2024-03-31 | 2024-05-09 | 39 | CVM ↗ |
| DFPanual | 2023-12-31 | 2024-03-25 | 85 | CVM ↗ |
| ITRT3 | 2023-09-30 | 2023-11-13 | 44 | CVM ↗ |
| ITRT2 | 2023-06-30 | 2023-08-14 | 45 | CVM ↗ |
| ITRT1 | 2023-03-31 | 2023-05-11 | 41 | CVM ↗ |
| DFPanual | 2022-12-31 | 2023-03-09 | 68 | CVM ↗ |
| ITRT3 | 2022-09-30 | 2022-11-10 | 41 | CVM ↗ |
When the next one is due
This is measured habit, not company guidance: the CVM publishes no forward calendar as open data. The estimate applies this company's historical median to the next period.